产时菌必治单次注射预防产褥感染临床对照分析

目的 观察产时菌必治单次注射预防产褥感染的疗效。方法 采用临床随机对照试验,对低危患者(169例)单次应用菌必治和未接受药物治疗之间疗效、高危患者(98例)单次菌必治和常规治疗方案之间的疗效进行对比分析。结果 产时单次应用菌必治注射,产褥感染和会阴切口感染率明显低于未接受药物治疗者(低危组),且与接受常规药物治疗者疗效相近(高危组)。结论 产时单次注射菌必治预防产褥感染和会阴切口感染,此方法简单,省时,经济,疗效明显。

A Randomised Controlled Trial of Prophylaxis of Puerperal Infection

Objective To investigate the incidence of puerperal infection after delivery in Women treated with a single-acting ceftriaxone. Methods Samples taken from October 1995 to May 1996 were randomly allocated to two groups :low risk patients group and high risk patients group. To see the incidence of puerperal infection and perinem incision infection in patients treated with single-acting ceftriaxone compared with low risk patients receiving no treatment and with high risk patients receiving standard treatment of penicillin and ampicillin. Results This study demonstrated a significant reduction in postpartum pelvic inflammatory disease and perinem incision infection in low risk patients treated with ceferiaxone. No significant difference was demonstrated between high risk patients treated with peniciuin and ampicillin. Conclasions A single-acting Ceferiaxone in women delivery should be populized